Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort study

BACKGROUND: Glioblastoma (GBM) is the most common malignant brain tumor in adults. The prognosis of GBM patients is poor. Even with active standard treatment, the median overall survival is only 14.6 months. It is therefore critical to ascertain recurrence and search for factors that influence the p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Transl Med
Main Authors: Zheng, Lin, Zhou, Zhi-Rui, Shi, Minghan, Chen, Haiyan, Yu, Qian-Qian, Yang, Yang, Liu, Lihong, Zhang, Lili, Guo, Yinglu, Zhou, Xiaofeng, Li, Chao, Wei, Qichun
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105825/
https://ncbi.nlm.nih.gov/pubmed/33987269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-21-673
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares